Literature DB >> 15063606

Effects of sex, age and BMI on screening tests for impaired glucose tolerance.

Mioko Gomyo1, Naoki Sakane, Isao Kamae, Shigeaki Sato, Ken-Ichi Suzuki, Makoto Tominaga, Shoji Kawazu, Hideyo Yoshinaga, Kazuyo Tsushita, Juichi Sato, Yuzo Sato, Satoru Tsujii, Toshihide Yoshida, Yutaka Seino, Takeshi Usui, Kishio Nanjo, Mari Hirata, Kazuhiko Kotani, Arimasa Hososako, Yutaka Kiyohara, Hideshi Kuzuya.   

Abstract

The discriminating abilities of fasting plasma glucose (FPG) and HbA1c were compared on screening tests for impaired glucose tolerance (IGT) and IGT plus diabetes mellitus by the receiver operating characteristic (ROC) curve analysis. Furthermore, effects of sex, age and BMI were examined on sensitivity and specificity of the optimal cutoff points. This study included 997 subjects who were recruited for 75 g OGTT after the first screening of the Japan Diabetes Prevention Program. According to the 1997 criteria of the American Diabetes Association (ADA), 140 subjects were classified as diabetic and 256 as IGT. The areas under the ROC curves of FPG were significantly larger than those of HbA1c. The optimal cutoff points of FPG were 102 mg/dl for IGT and 105 mg/dl for IGT plus diabetes mellitus. Those of HbA1c were both 5.3%. In screening with FPG, females had significantly lower sensitivity and higher specificity than males, and the specificity for IGT plus diabetes mellitus was the lowest in the obese group. In screening with HbA1c, the specificity was low in the older and the obese groups. We concluded that FPG was superior to HbA1c for screening of IGT and IGT plus diabetes mellitus and the optimal cutoff point of FPG would be 102 mg/dl or greater.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063606     DOI: 10.1016/j.diabres.2003.10.019

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.

Authors:  M S Hutchinson; R M Joakimsen; I Njølstad; H Schirmer; Y Figenschau; R Jorde
Journal:  J Endocrinol Invest       Date:  2011-12-16       Impact factor: 4.256

2.  Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance.

Authors:  Naoki Sakane; Juichi Sato; Kazuyo Tsushita; Satoru Tsujii; Kazuhiko Kotani; Kokoro Tsuzaki; Makoto Tominaga; Shoji Kawazu; Yuzo Sato; Takeshi Usui; Isao Kamae; Toshihide Yoshida; Yutaka Kiyohara; Shigeaki Sato; Hideshi Kuzuya
Journal:  BMC Public Health       Date:  2011-01-17       Impact factor: 3.295

3.  A Comparison of HbA1c and Fasting Blood Sugar Tests in General Population.

Authors:  Zahra Ghazanfari; Ali Akbar Haghdoost; Sakineh Mohammad Alizadeh; Jamileh Atapour; Farzaneh Zolala
Journal:  Int J Prev Med       Date:  2010

4.  Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol(®) on glycemic control of subjects with impaired fasting glucose.

Authors:  Malkanthi Evans; William V Judy; Dale Wilson; John A Rumberger; Najla Guthrie
Journal:  Diabetes Metab Syndr Obes       Date:  2015-06-25       Impact factor: 3.168

5.  Effect of baseline HbA1c level on the development of diabetes by lifestyle intervention in primary healthcare settings: insights from subanalysis of the Japan Diabetes Prevention Program.

Authors:  Naoki Sakane; Juichi Sato; Kazuyo Tsushita; Satoru Tsujii; Kazuhiko Kotani; Makoto Tominaga; Shoji Kawazu; Yuzo Sato; Takeshi Usui; Isao Kamae; Toshihide Yoshida; Yutaka Kiyohara; Shigeaki Sato; Kokoro Tsuzaki; Kaoru Takahashi; Hideshi Kuzuya
Journal:  BMJ Open Diabetes Res Care       Date:  2014-04-23

6.  Determinants of Glycated Hemoglobin in Subjects With Impaired Glucose Tolerance: Subanalysis of the Japan Diabetes Prevention Program.

Authors:  Naoki Sakane; Juichi Sato; Kazuyo Tsushita; Satoru Tsujii; Kazuhiko Kotani; Makoto Tominaga; Shoji Kawazu; Yuzo Sato; Takeshi Usui; Isao Kamae; Toshihide Yoshida; Yutaka Kiyohara; Shigeaki Sato; Kokoro Tsuzaki; Shinsuke Nirengi; Kaoru Takahashi; Hideshi Kuzuya; Jdpp Research Group
Journal:  J Clin Med Res       Date:  2017-02-21

7.  Prevalence and Risk Factors of Elevated Liver Enzymes in Japanese Women With Polycystic Ovary Syndrome.

Authors:  Satomi Minato; Naoki Sakane; Kazuhiko Kotani; Shinsuke Nirengi; Ikuyo Hayashi; Akiko Suganuma; Ken Yamaguchi; Kenji Takakura; Narumi Nagai
Journal:  J Clin Med Res       Date:  2018-10-30

8.  Effects of lifestyle intervention on weight and metabolic parameters in patients with impaired glucose tolerance related to beta-3 adrenergic receptor gene polymorphism Trp64Arg(C/T): Results from the Japan Diabetes Prevention Program.

Authors:  Naoki Sakane; Juichi Sato; Kazuyo Tsushita; Satoru Tsujii; Kazuhiko Kotani; Makoto Tominaga; Shoji Kawazu; Yuzo Sato; Takeshi Usui; Isao Kamae; Toshihide Yoshida; Yutaka Kiyohara; Shigeaki Sato; Kokoro Tsuzaki; Kaoru Takahashi; Hideshi Kuzuya
Journal:  J Diabetes Investig       Date:  2015-10-29       Impact factor: 4.232

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.